Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 5OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 63Neoplasms 40Colorectal Neoplasms 30Uterine Cervical Neoplasms 29Carcinoma, Hepatocellular 23Stomach Neoplasms 19Prostatic Neoplasms 19Carcinoma, Non-Small-Cell Lung 19Ovarian Neoplasms 16Lung Neoplasms 14Esophageal Neoplasms 13Multiple Myeloma 12Pancreatic Neoplasms 11Endometrial Neoplasms 10Urinary Bladder Neoplasms 9Motor Activity 9Colonic Neoplasms 9Recurrence 8Rectal Neoplasms 8Lymphoma, Follicular 8Melanoma 7Lymphoma 7Liver Neoplasms 7Carcinoma, Ovarian Epithelial 7Triple Negative Breast Neoplasms 6Sleep Initiation and Maintenance Disorders 6Sarcopenia 6Neuroendocrine Tumors 6Leukemia 6Hematologic Neoplasms 6

Interventions

pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Advanced Solid Tumours × 1 year × Clear all
NCT05701527 2026-02-05

A Study of EBC-129 in Advanced Solid Tumours

EDDC (Experimental Drug Development Centre), A*STAR Research Entities

Phase 1 Recruiting
98 enrolled
Other solid neoplasm

Advanced Solid Tumours

Data powered by HemOnc (CC BY 4.0) Colophon âš¡